SVB Leerink Downgrades Arena Pharma (ARNA) to Market Perform
Tweet Send to a Friend
SVB Leerink analyst Joshua Schwartz downgraded Arena Pharma (NASDAQ: ARNA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
